Clinical Outcomes of Patients Treated With Idarucizumab for Dabigatran Reversal versus Four-factor Prothrombin Complex Concentrate for Warfarin Reversal

被引:0
|
作者
Clare, Ryan
Hekimian, Avetis
Rafie, Reza
Kim, Cy
Shen, Albert Y.
Lee, Mingsum
机构
关键词
Anticoagulation;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
16796
引用
收藏
页数:2
相关论文
共 50 条
  • [1] EVALUATION OF FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE DOSING IN WARFARIN REVERSAL
    Fitter, Scott
    Le, Huy
    Parbuoni, Kristine
    Bushell, Thomas
    CRITICAL CARE MEDICINE, 2016, 44 (12)
  • [2] Updated recommendations for warfarin reversal in the setting of four-factor prothrombin complex concentrate
    Robinson, Danielle
    Mcfadyen, James
    Merriman, Eileen
    Wee, Tan Chee
    Baker, Ross
    Tran, Huyen
    MEDICAL JOURNAL OF AUSTRALIA, 2025, 222 (01) : 49 - 51
  • [3] THREE-VERSUS FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE FOR REVERSAL OF WARFARIN-INDUCED BLEEDING
    Holt, Tara
    Taylor, Scott
    Abraham, Prasad
    McMillian, Wesley
    Elder, Tai
    Harris, Serena
    Curtis, Jim
    CRITICAL CARE MEDICINE, 2015, 43 (12)
  • [4] Four-factor prothrombin complex concentrate dose response relationship with INR for warfarin reversal
    Yohe, Alexander S.
    Livings, Sarah E.
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2019, 37 (08): : 1534 - 1538
  • [5] Evaluation of modified fixed dose four-factor prothrombin complex concentrate for warfarin reversal
    Peterson, Meghan E.
    Jaynes, Megan P.
    Berardi, Sarah
    Morton, Colleen
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2024, 57 (05) : 865 - 870
  • [6] Three-Factor Versus Four-Factor Prothrombin Complex Concentrate for Warfarin Reversal-A Critical Appraisal of the Evidence
    Jones, G. Morgan
    Davidson, K. Erin
    AMERICAN JOURNAL OF THERAPEUTICS, 2018, 25 (03) : E375 - E377
  • [7] Four-Factor Prothrombin Complex Concentrate for Coagulopathy Reversal in Patients With Liver Disease
    Huang, Wan-Ting
    Cang, William C.
    Derry, Katrina L.
    Lane, James R.
    von Drygalski, Annette
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2017, 23 (08) : 1028 - 1035
  • [8] EVALUATION OF MODIFIED FIXED-DOSE FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE FOR WARFARIN REVERSAL
    Peterson, Meghan
    Jaynes, Megan
    Berardi, Sarah
    Morton, Colleen
    CRITICAL CARE MEDICINE, 2024, 52
  • [9] Four-factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors versus Warfarin in Life-threatening Bleeding
    Rech, Megan A.
    Masic, Dalila
    Hammond, Drayton A.
    WESTERN JOURNAL OF EMERGENCY MEDICINE, 2021, 22 (02) : 163 - 169
  • [10] COST ADVANTAGE OF FIXED-DOSE FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE FOR WARFARIN REVERSAL
    Lucarelli, Stefani
    Miller, Kirsten
    Troyer, Camille
    Huang, Wan-Ting
    Park, Jung Hoon
    CRITICAL CARE MEDICINE, 2024, 52